https://www.selleckchem.com/pr....oducts/nms-p937-nms1
The three-month HFS rate was 52.1%. There was a significant difference in the three-month HFS rate between patients with and without a history of pretreatment blood transfusion (HFS rate 34.6% vs. 61.5%, p = 0.03). Grade 2 urinary tract pain and grade 3 diarrhea were seen in one patient each. Conclusion Palliative RT appeared to be effective with limited toxicities for urothelial cancer patients with MH.Background The intensity of predeath grief is associated with postdeath grief in family caregivers of patients in palliativ
Like
Comment
Share
